Use of Aspirin was Found to Reduce Prostate Cancer Risk

Recent interest in the role of inflammation has sparked many studies to evaluate whether aspirin or other nonsteroidal anti-inflammatory drugs can prevent cancers.

In a case-control study designed to investigate the relation between pain relievers and prostate cancer risk, investigators evaluated the relationship between the use of anti-inflammatory drugs and the risk of prostate caner in 2000 individuals between 2002 and 2005.

The investigator found that use of aspirin was association with a significant 21% reduction in the risk of prostate cancer when compared with aspirin nonusers.